New

North America Artificial Cornea and Corneal Implant Market

2021

North America Artificial Cornea and Corneal Implant Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Human Cornea and Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty, and Others), Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, and Others), and End User (Hospitals, Specialty Clinics and ASCs, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025843 | No. of Pages: 109 | Category: Pharmaceuticals | Status: Published

Market Insights

North America Artificial Cornea and Corneal Implant Market to Grow at a CAGR of 7.4% to reach US$ 196.62 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The North America artificial cornea and corneal implant market is expected to reach US$ 272.13 million by 2028 from US$ 162.29 million in 2021; it is estimated to grow at a CAGR of 7.7% from 2021–2028.


The growth of the Artificial Cornea and Corneal Implantmarket is attributed to key factors such as the growing prevalence of eye diseases that can cause corneal blindness and rising elderly population. However, the expensive ophthalmology surgeries and devices hamper the market growth.

Corneal diseases are the second-leading cause of blindness worldwide, after cataract. According to the World Health Organization (WHO), at least 2.2 billion people in the world will have near or far vision impairment by February 2020. These 1 billion people include people with moderate or severe distance vision impairment or blindness due to refractive errors (88.4 million), cataracts (94 million), glaucoma (7.7 million), corneal opacity (4.2 million), diabetes Retinopathy (3.9 million), trachoma (2 million), and near vision weakness due to unresolved presbyopia (826 million). Population growth and aging would further propel the risk of visual impairment among a larger number of people. According to the National Eye Institute, the number of persons suffering from cataract would rise from 24.4 million in 2010 to ~50 million by 2050. As populations age and average life expectancy continues to increase worldwide, the number of people with cataracts will continue to grow. Furthermore, people over 60 years of age; steroid users; and family members of those who have been diagnosed with glaucoma; people suffering from diabetes, high myopia, and hypertension, and eye injuries are at a greater risk of glaucoma. Thus, the rising prevalence of eye diseases that causes corneal blindness worldwide highly demands artificial cornea and corneal implant. Also, the rise in geriatric population is fuelling the artificial cornea and corneal implant market growth.

The COVID-19 outbreak in North America had a significant impact on the US. Various healthcare research centers across the country were solely focused on COVID-19 treatments. On the other hand, to prevent the spread of the novel coronavirus, the number of patient visits to clinics decreased significantly in the first and second quarters of 2020. As a result, the number of elective eye procedures performed per week in hospitals and clinics has decreased over time. According to an article in Ophthalmology Times, the number of elective procedures has decreased from 200 to only 10 each week in U.S. In addition, the number of patient visits to examination facilities has decreased by 15% in countries, such as the US. Also, it is predicated that the volume of ophthalmic practice has decreased by 81%, owing to a decline in patients seeking care for glaucoma (88%) and cataract surgery (81%) (97%). During this time, government assistance such as Paycheck Protection Program loans aided many practices, allowing the ophthalmic business to successfully resume operations. Ophthalmologists will benefit from such a scenario since it will allow them to resume their work safely.

Artificial Cornea and Corneal Implantmarket

Get more information on this report :


NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET SEGMENTATION

By Type

  • Human Cornea
  • Artificial Cornea

By Transplant Type

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Others

By Disease Indication

  • Fuchs’ Dystrophy
  • Keratoconus
  • Fungal Keratitis
  • Others

By End User

  • Hospitals
  • Specialty Clinics and ASCs
  • Others

By Country

  • US
  • Canada
  • Mexico

Company Profiles

  • AJL OPHTHALMIC S.A
  • ADVANCING SIGHT NETWORK
  • CORNEA BIOSCIENCES, INC
  • KERAMED, INC
  • EyeYon Medical
  • Florida Lions Eye Bank
  • CorneaGen

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Artificial Cornea and Corneal Implant Market – By Type

1.3.2 North America Artificial Cornea and Corneal Implant Market – By Transplant Type

1.3.3 North America Artificial Cornea and Corneal Implant Market – By Disease Indication

1.3.4 North America Artificial Cornea and Corneal Implant Market – By End User

1.3.5 North America Artificial Cornea and Corneal Implant Market – By Country

2. Artificial Cornea and Corneal Implant Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Artificial Cornea and Corneal Implant Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

5. Artificial Cornea and Corneal Implant Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Eye Diseases Causing Corneal Blindness

5.1.2 Significant Rise in Elderly Population

5.2 Market Restraints

5.2.1 Expensive Ophthalmology Surgeries and Devices

5.3 Market Opportunities

5.3.1 Shortage of Corneal Donors

5.4 Future Trends

5.4.1 3D-Printed Human Corneas

5.5 Impact Analysis

6. Artificial Cornea and Corneal Implant Market –North America Analysis

6.1 North America Artificial Cornea and Corneal Implant Market Revenue Forecast and Analysis

7. Artificial Cornea and Corneal Implant Market Analysis – By Type

7.1 Overview

7.2 Artificial Cornea and Corneal Implant Market, by Type 2021 & 2028 (%)

7.3 Human Cornea

7.3.1 Overview

7.3.2 Human Cornea: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Artificial Cornea

7.4.1 Overview

7.4.2 Artificial Cornea: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

8. Artificial Cornea and Corneal Implant Market Analysis – By Transplant Type

8.1 Overview

8.2 Artificial Cornea and Corneal Implant Market, by Transplant Type 2021 & 2028 (%)

8.3 Penetrating Keratoplasty

8.3.1 Overview

8.3.2 Penetrating Keratoplasty: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Endothelial Keratoplasty

8.4.1 Overview

8.4.2 Endothelial Keratoplasty: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

9. Artificial Cornea and Corneal Implant Market Analysis – By Disease Indication

9.1 Overview

9.2 Artificial Cornea and Corneal Implant Market Revenue Share, by Disease Indication (2021 and 2028)

9.3 Fuchs’ Dystrophy

9.3.1 Overview

9.3.2 Fuchs’ Dystrophy: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Keratoconus

9.4.1 Overview

9.4.2 Keratoconus: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Fungal Keratitis

9.5.1 Overview

9.5.2 Fungal Keratitis: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

10. Artificial Cornea and Corneal Implant Market Analysis – By End User

10.1 Overview

10.2 Artificial Cornea and Corneal Implant Market Revenue Share, by End User (2021 and 2028)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Specialty Clinics and ASCs

10.4.1 Overview

10.4.2 Specialty Clinics and ASCs: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

11. Artificial Cornea and Corneal Implant Market –North America Analysis

11.1 North America: Artificial Cornea and Corneal Implant Market

11.1.1 Overview

11.1.2 North America: Artificial Cornea and Corneal Implant Market - Revenue and Forecast to 2028 (USD Million)

11.1.3 North America Artificial Cornea and Corneal Implant Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.4 North America Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)

11.1.5 North America Artificial Cornea and Corneal Implant Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

11.1.6 North America Artificial Cornea and Corneal Implant Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7 North America: Artificial Cornea and Corneal Implant Market, by Country, 2021 & 2028 (%)

11.1.7.1 US: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.1 US: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.2 US Artificial Cornea and Corneal Implant Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.3 US Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.4 US Artificial Cornea and Corneal Implant Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.5 US Artificial Cornea and Corneal Implant Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.2 Canada: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.1 Canada: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.2 Canada Artificial Cornea and Corneal Implant Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.3 Canada Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.4 Canada Artificial Cornea and Corneal Implant Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.5 Canada Artificial Cornea and Corneal Implant Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.3 Mexico: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.1 Mexico: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.2 Mexico Artificial Cornea and Corneal Implant Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.3 Mexico Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.4 Mexico Artificial Cornea and Corneal Implant Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.5 Mexico Artificial Cornea and Corneal Implant Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on North America Artificial Cornea and Corneal Implant Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Artificial Cornea and Corneal Implant Market–Industry Landscape

13.1 Overview

13.2 Inorganic Growth Strategies

13.2.1 Overview

13.3 Organic Growth Strategies

13.3.1 Overview

14. Company Profiles

14.1 AJL OPHTHALMIC S.A

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 ADVANCING SIGHT NETWORK

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 CORNEA BIOSCIENCES, INC.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 KERAMED, INC.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 EyeYon Medical

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Florida Lions Eye Bank

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 CorneaGen

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms


LIST OF TABLES

Table 1. North America Artificial Cornea and Corneal Implant Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2. North America Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Artificial Cornea and Corneal Implant Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 4. North America Artificial Cornea and Corneal Implant Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. US Artificial Cornea and Corneal Implant Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 6. US Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)

Table 7. US Artificial Cornea and Corneal Implant Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 8. US Artificial Cornea and Corneal Implant Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada Artificial Cornea and Corneal Implant Market, by Type -Revenue and Forecast to 2028 (USD Million)

Table 10. Canada Artificial Cornea and Corneal Implant Market, by Transplant Type - Revenue and Forecast to 2028 (USD Million)

Table 11. Canada Artificial Cornea and Corneal Implant Market, by Disease Indication - Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Artificial Cornea and Corneal Implant Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Mexico Artificial Cornea and Corneal Implant Market, by Type -Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico Artificial Cornea and Corneal Implant Market, by Transplant Type – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico Artificial Cornea and Corneal Implant Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico Artificial Cornea and Corneal Implant Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Recent Inorganic Growth Strategies in the Artificial Cornea and Corneal Implant Market

Table 18. Recent Organic Growth Strategies in the Artificial Cornea and Corneal Implant Market

Table 19. Glossary of Terms, Artificial Cornea and Corneal Implant Market


LIST OF FIGURES

Figure 1. Artificial Cornea and Corneal Implant Market Segmentation

Figure 2. Artificial Cornea and Corneal Implant Market Segmentation, By Country

Figure 3. North America Artificial Cornea and Corneal Implant Market Overview

Figure 4. Human Cornea Segment Held the Largest Share of the Type Segment in Artificial Cornea and Corneal Implant Market

Figure 5. North America Artificial Cornea and Corneal Implant Market – Leading Country Markets (US$ Million)

Figure 6. North America PEST Analysis

Figure 7. North America Artificial Cornea and Corneal Implant Market – Revenue Forecast and Analysis – 2020- 2028

Figure 8. Artificial Cornea and Corneal Implant Market, by Type 2021 & 2028 (%)

Figure 9. Human Cornea: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Artificial Cornea: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Artificial Cornea and Corneal Implant Market, by Transplant Type 2021 & 2028 (%)

Figure 12. Penetrating Keratoplasty: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Endothelial Keratoplasty: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Artificial Cornea and Corneal Implant Market Revenue Share, by (2021 and 2028)

Figure 16. Fuchs’ Dystrophy: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Keratoconus: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Fungal Keratitis: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Artificial Cornea and Corneal Implant Market Revenue Share, by End User (2021 and 2028)

Figure 21. Hospitals & Clinics: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Specialty Clinics and ASCs: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Others: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. North America: Artificial Cornea and Corneal Implant Market, by Key Country – Revenue (2021) (USD Million)

Figure 25. North America Artificial Cornea and Corneal Implant Market Revenue and Forecast to 2028 (USD Million)

Figure 26. North America: Artificial Cornea and Corneal Implant Market, by Country, 2021 & 2028 (%)

Figure 27. US: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. Canada: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Mexico: Artificial Cornea and Corneal Implant Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Impact of COVID-19 Pandemic in North American Country Markets

  1. AJL OPHTHALMIC S.A
  2. ADVANCING SIGHT NETWORK
  3. CORNEA BIOSCIENCES, INC
  4. KERAMED, INC
  5. EyeYon Medical
  6. Florida Lions Eye Bank
  7. CorneaGen
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America artificial cornea and corneal implant market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America artificial cornea and corneal implant market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution. 
TIPRE00025843
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.